Literature DB >> 23483861

Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

David G Binion1.   

Abstract

Entities:  

Year:  2012        PMID： 23483861      PMCID： PMC3594958     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  4 in total

Review 1.  Clostridium difficile infection: the scope of the problem.

Authors:  Erik Dubberke
Journal:  J Hosp Med       Date:  2012-03       Impact factor: 2.960

2.  Clostridium difficile and inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; Mazen Issa; David G Binion
Journal:  Med Clin North Am       Date:  2010-01       Impact factor: 5.456

3.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Authors:  L Kyne; M Warny; A Qamar; C P Kelly
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

Review 4.  Impact of Clostridium difficile on inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan; David G Binion
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 3.869
  4 in total
  10 in total

Review 1.  Clostridium difficile infection in inflammatory bowel disease: challenges in diagnosis and treatment.

Authors:  Ying M Tang; Christian D Stone
Journal:  Clin J Gastroenterol       Date:  2017-02-16

Review 2.  Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation.

Authors:  Seong Ran Jeon; Jocelyn Chai; Christiana Kim; Christine H Lee
Journal:  Curr Infect Dis Rep       Date:  2018-05-26       Impact factor: 3.725

Review 3.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

4.  Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

Authors:  Colleen R Kelly; Chioma Ihunnah; Monika Fischer; Alexander Khoruts; Christina Surawicz; Anita Afzali; Olga Aroniadis; Amy Barto; Thomas Borody; Andrea Giovanelli; Shelley Gordon; Michael Gluck; Elizabeth L Hohmann; Dina Kao; John Y Kao; Daniel P McQuillen; Mark Mellow; Kevin M Rank; Krishna Rao; Arnab Ray; Margot A Schwartz; Namita Singh; Neil Stollman; David L Suskind; Stephen M Vindigni; Ilan Youngster; Lawrence Brandt
Journal:  Am J Gastroenterol       Date:  2014-06-03       Impact factor: 10.864

5.  Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.

Authors:  Joshua R Fletcher; Colleen M Pike; Ruth J Parsons; Alissa J Rivera; Matthew H Foley; Michael R McLaren; Stephanie A Montgomery; Casey M Theriot
Journal:  Nat Commun       Date:  2021-01-19       Impact factor: 14.919

Review 6.  Bacterial Species Associated With Human Inflammatory Bowel Disease and Their Pathogenic Mechanisms.

Authors:  Li Zhang; Fang Liu; Jessica Xue; Seul A Lee; Lu Liu; Stephen M Riordan
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

7.  Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis.

Authors:  Colleen M Pike; John Tam; Roman A Melnyk; Casey M Theriot
Journal:  Infect Immun       Date:  2022-07-07       Impact factor: 3.609

8.  Inflammatory Bowel Disease Outcomes Following Fecal Microbiota Transplantation for Recurrent C. difficile Infection.

Authors:  Jessica R Allegretti; Colleen R Kelly; Ari Grinspan; Benjamin H Mullish; Jonathan Hurtado; Madeline Carrellas; Jenna Marcus; Julian R Marchesi; Julie A K McDonald; Ylaine Gerardin; Michael Silverstein; Alexandros Pechlivanis; Grace F Barker; Jesus Miguens Blanco; James L Alexander; Kate I Gallagher; Will Pettee; Emmalee Phelps; Sara Nemes; Sashidhar V Sagi; Matthew Bohm; Zain Kassam; Monika Fischer
Journal:  Inflamm Bowel Dis       Date:  2021-08-19       Impact factor: 5.325

Review 9.  Fecal microbiota transplantation: current clinical efficacy and future prospects.

Authors:  Kathryn A Bowman; Elizabeth K Broussard; Christina M Surawicz
Journal:  Clin Exp Gastroenterol       Date:  2015-10-23

10.  Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review.

Authors:  Bhupinder S Romana; Abdulmajeed A Albarrak; Mohamad H Yousef; Veysel Tahan
Journal:  North Clin Istanb       Date:  2018-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.